DEFINITIVE PROXY STATEMENT

Company

KIORA PHARMACEUTICALS INC

Filed

May 29, 2018

Period of Report

July 10, 2018

Accession Number

0001571049-18-000320

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →